4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000451
Options or other derivatives
- SVP & Chief Scientific Officer acquired 9,924 shares (grant or award)
- SVP & Chief Scientific Officer returned 23,201 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −2,072 | 0 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −2,779 | 0 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −3,908 | 0 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −2,407 | 0 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −2,407 | 0 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −4,814 | 0 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Returned to the company · Stock Option (right to buy) | −4,814 | 0 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Grant or award · Stock Option (right to buy) | +7,784 | 7,784 | D | ||
| Gross Jane A SVP & Chief Scientific Officer | 2020-07-27 | Grant or award · Stock Option (right to buy) | +2,140 | 2,140 | D | ||
Loading xslF345X03/gross.xml…